Abstract
In patients with burns, bone exposure accompanies serious problems which occasionally lead to amputation. We present a case of an 82-year-old woman who sustained 22% of total body surface area flame burns on her bilateral lower extremities with bone exposure. Despite fascial excision and mesh skin graft, muscles, bones, and tendons were widely exposed on her right leg. The wound was infected by methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. To promote wound healing, we applied an allogeneic cultured dermal substitute (CDS) to the wound surface once weekly, resulting in healthy granulation except for the exposed bone area of the right anterior tibia. We then shaved the cortex of the exposed bone surface until bone marrow bleeding, and grafted mesh skin in combination with CDS. Finally, all wounds healed without osteomyelitis. The use of CDS to treat deep burns exposing bone surface may expand reconstructive options for extremities that otherwise might have been amputated.
Similar content being viewed by others
References
Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation. J Biomater Sci Polymer Edn. 2003;14:625–41.
Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute; evaluation in an animal test. J Artif Organs. 2003;6:64–70.
Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs. 2003;6:138–44.
Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs. 2004;28:444–50.
Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, et al. Digital gangrene associated with idiopathic hypereosinophilia; treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol. 2004;14:168–71.
Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, et al. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol. 2004;14:172–6.
Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, et al. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2004;50:803–4.
Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, et al. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports. J Dermatol. 2005;32:715–20.
Kishioka A, Yamamoto Y, Furukawa F, Kawasaki S, Shinozaki M, Hashimoto A, et al. Report of a case of burns to both legs successfully treated with cultured dermal substitute. Jpn J Burn Injuries. 2006;32:48–52.
Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Mizuno Y, Haruna K, et al. Intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute. Scand J Plast Reconstr Surg Hand Surg. 2007;41:326–8.
Yonezawa M, Tanizaki H, Inoguchi N, Ishida M, Katoh M, Tachibana T, et al. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. Int J Dermatol. 2007;46:36–42.
Nishimoto J, Amoh Y, Tanabe K, Niiyama N, Katsuoka K, Kuroyanagi Y. Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute. Eur J Dermatol. 2007;17:350–1.
Yamada N, Uchinuma E, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for intractable skin ulcers of the lower leg. J Artif Organs. 2008;11:100–3.
Yamada N, Uchinuma E, Matsumoto Y, Kuroyanagi Y. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute. J Artif Organs. 2008;11:221–4.
Toyozawa S, Yamamoto Y, Nishide T, Kishioka A, Kanazawa N, Matsumoto Y, et al. Case report; a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes. Dermatol Online J. 2008;14:17.
Kuroyanagi Y, Kubo K, Matsui H, Kim HJ, Numari S, Mabuchi Y, et al. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs. 2004;28:13–21.
Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs. 2003;6:267–72.
Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts; cryopreservation. Artif Organs. 2004;28:182–8.
Kubo K, Kuroyanagi Y. The possibility of long-term cryopreservation of cultured dermal substitute. Artif Organs. 2005;29:800–5.
Kubo K, Kuroyanagi Y. A study of cytokines released from fibroblasts in cultured dermal substitute. Artifi Organs. 2005;29:845–9.
Hashimoto A, Kuroyanagi Y. Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-β, and IL-8. J Artif Organs. 2008;11:225–31.
Clarke RA. Overview and general considerations of wound repair. In: Clarke RAF, Henson PM, editors. The molecular and cellular biology of wound repair. New York: Plenum; 1988. p. 18–22.
Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA. 1978;75:871–5.
Cohn RH, Cassiman JJ, Bernfield MR. Relationship of transformation, cell density and growth control to cellular distribution of newly synthesized glycosaminoglycan. J Cell Biol. 1976;71:280–94.
Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials. 1993;14:1154–60.
Heymans O, Verhelle N, Peters S, Nélissen X, Oelbrandt B. Use of the medial adipofascial flap of the leg for coverage of full-thickness burns exposing the tibial crest. Burns. 2002;28:674–8.
Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974;249:123–7.
Yokouchi T, Daian T. Combined therapy of artificial dermis and bFGF for exposed leg bone. Med Consult New Remedies. 2005;42:1117–8.
Acknowledgments
This study was approved by the Ethics Committee of Hiroshima University. This work was supported by a grant from the Regenerating Medical Millennium Project of the Ministry of Health, Labor and Welfare. The allogeneic cultured dermal substitutes were prepared at the R&D Center for Artificial Skin of Kitasato University, Kanagawa, Japan.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ohara, N., Mihara, S., Nihara, H. et al. A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute. J Artif Organs 13, 101–105 (2010). https://doi.org/10.1007/s10047-010-0499-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-010-0499-7